| |
| | The Biomedical Executive Forum (Site not responding. Last check: 2007-11-03) |
 | | CryoLife, Inc. (NYSE: CRY), a biomaterials and biosurgical device company, announced today that CryoLife and The Magdi Yacoub Institute, at the Imperial College, London, UK, have entered into a three year research collaboration to develop methods to improve the utilization of unfixed xenografts (animal tissues) for human transplantation. |
 | | This research effort will leverage The Magdi Yacoub Institute's extensive knowledge of heart valve structure and biochemistry, and is designed to optimize decellularization technology in the preparation of animal tissues for human implantation. |
 | | For almost 10 years, Professor Yacoub's group has been among the foremost laboratories in the world that centers its efforts to define and characterize heart valve cells and their activities. |
| www.biomedexec.com /newsfeed/article.asp?article=1231037 (589 words) |
|